...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

Unless they had reason to collect data on ACE conc and dose, they might not be sufficient. Ideally, you would need to look at several doses.

Share
New Message
Please login to post a reply